125 related articles for article (PubMed ID: 12526158)
1. Improved HSV-1 amplicon packaging system using ICP27-deleted, oversized HSV-1 BAC DNA.
Saeki Y; Breakefield XO; Chiocca EA
Methods Mol Med; 2003; 76():51-60. PubMed ID: 12526158
[No Abstract] [Full Text] [Related]
2. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
[TBL] [Abstract][Full Text] [Related]
3. Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes.
Zaupa C; Revol-Guyot V; Epstein AL
Hum Gene Ther; 2003 Jul; 14(11):1049-63. PubMed ID: 12885345
[TBL] [Abstract][Full Text] [Related]
4. Gene delivery using helper virus-free HSV-1 amplicon vectors.
Laimbacher AS; Fraefel C
Curr Protoc Neurosci; 2012 Jul; Chapter 4():Unit 4.14. PubMed ID: 22752894
[TBL] [Abstract][Full Text] [Related]
5. Gene delivery using helper virus-free HSV-1 amplicon vectors.
Fraefel C
Curr Protoc Neurosci; 2007 Jul; Chapter 4():Unit 4.14. PubMed ID: 18428655
[TBL] [Abstract][Full Text] [Related]
6. Gene delivery using helper virus-free HSV-1 amplicon vectors.
Fraefel C
Curr Protoc Hum Genet; 2002 Aug; Chapter 12():Unit 12.12. PubMed ID: 18428323
[TBL] [Abstract][Full Text] [Related]
7. An enhanced packaging system for helper-dependent herpes simplex virus vectors.
Stavropoulos TA; Strathdee CA
J Virol; 1998 Sep; 72(9):7137-43. PubMed ID: 9696807
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.
Saeki Y; Ichikawa T; Saeki A; Chiocca EA; Tobler K; Ackermann M; Breakefield XO; Fraefel C
Hum Gene Ther; 1998 Dec; 9(18):2787-94. PubMed ID: 9874276
[TBL] [Abstract][Full Text] [Related]
9. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex amplicon vectors.
Link CJ; Vahanian NN; Wang S
Methods Mol Med; 2003; 76():61-87. PubMed ID: 12526159
[No Abstract] [Full Text] [Related]
11. Construction of HSV-1 BACs and their use for packaging of HSV-1-based amplicon vectors.
Heister TG; Vögtlin A; Müller L; Heid I; Fraefel C
Methods Mol Biol; 2004; 256():241-56. PubMed ID: 15024170
[No Abstract] [Full Text] [Related]
12. Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers.
Bowers WJ; Howard DF; Brooks AI; Halterman MW; Federoff HJ
Gene Ther; 2001 Jan; 8(2):111-20. PubMed ID: 11313780
[TBL] [Abstract][Full Text] [Related]
13. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
[TBL] [Abstract][Full Text] [Related]
14. A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus.
Logvinoff C; Epstein AL
Hum Gene Ther; 2001 Jan; 12(2):161-7. PubMed ID: 11177553
[TBL] [Abstract][Full Text] [Related]
15. Hexamethylene bisacetamide leads to reduced helper virus-free HSV-1 amplicon expression titers via suppression of ICP0.
Burris CA; de Silva S; Narrow WC; Casey AE; Lotta LT; Federoff HJ; Bowers WJ
J Gene Med; 2008 Feb; 10(2):152-64. PubMed ID: 18058952
[TBL] [Abstract][Full Text] [Related]
16. An HSV amplicon-based helper system for helper-dependent adenoviral vectors.
Kubo S; Saeki Y; Chiocca EA; Mitani K
Biochem Biophys Res Commun; 2003 Aug; 307(4):826-30. PubMed ID: 12878185
[TBL] [Abstract][Full Text] [Related]
17. An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells.
Lee CY; Bu LX; Rennie PS; Jia WW
Cancer Gene Ther; 2007 Jul; 14(7):652-60. PubMed ID: 17479106
[TBL] [Abstract][Full Text] [Related]
18. A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors.
Pechan PA; Fotaki M; Thompson RL; Dunn R; Chase M; Chiocca EA; Breakefield XO
Hum Gene Ther; 1996 Oct; 7(16):2003-13. PubMed ID: 8930661
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus type 1-derived recombinant and amplicon vectors.
Fraefel C; Marconi P; Epstein AL
Methods Mol Biol; 2011; 737():303-43. PubMed ID: 21590403
[TBL] [Abstract][Full Text] [Related]
20. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals.
Berthomme H; Fournel S; Epstein AL
Virology; 1996 Feb; 216(2):437-43. PubMed ID: 8607275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
